214
Views
2
CrossRef citations to date
0
Altmetric
Review Articles

Molecular mechanisms of hepatotoxicity induced by compounds occurring in Evodiae Fructus

, , , , , & show all
Pages 75-93 | Received 17 Jun 2022, Accepted 08 Feb 2023, Published online: 20 Feb 2023

References

  • Akl H, Vervloessem T, Kiviluoto S, Bittremieux M, Parys JB, De Smedt H, Bultynck G. 2014. A dual role for the anti-apoptotic Bcl-2 protein in cancer: mitochondria versus endoplasmic reticulum. Biochim Biophys Acta. 1843(10):2240–2252.
  • Argikar UA. 2012. Unusual glucuronides. Drug Metab Dispos. 40(7):1239–1251.
  • Ashraf NU, Sheikh TA. 2015. Endoplasmic reticulum stress and oxidative stress in the pathogenesis of Non-alcoholic fatty liver disease. Free Radic Res. 49(12):1405–1418.
  • Bjellerup M, Bruze M, Hansson A, Krook G, Ljunggren B. 1979. Liver injury following administration of 8-methoxypsoralen during PUVA therapy. Acta Derm Venereol. 59(4):371–372.
  • Cai Q, Wei J, Zhao W, Shi S, Zhang Y, Wei R, Zhang Y, Li W, Wang Q. 2014. Toxicity of Evodiae Fructus on rat liver mitochondria: the role of oxidative stress and mitochondrial permeability transition. Molecules. 19(12):21168–21182.
  • Cao L, Chen H, Huang Y, Chen L, Kang M, Liang J. 2021. The pharmacological activity of the Wenjing decoction in recurrent spontaneous abortion. Evid Based Complement Alternat Med. 2021:8861394.
  • Cao X, Liu Y, Wang M, Sun L, Ren X. 2019. Study on the source and characteristics of Evodia rutaecarpa based on chemical pattern recognition. Nat Prod Res. 33(14):2113–2115.
  • Cedó L, Santos D, Roglans N, Julve J, Pallarès V, Rivas-Urbina A, Llorente-Cortes V, Laguna JC, Blanco-Vaca F, Escolà-Gil JC. 2017. Human hepatic lipase overexpression in mice induces hepatic steatosis and obesity through promoting hepatic lipogenesis and white adipose tissue lipolysis and fatty acid uptake. PLoS One. 12(12):e0189834.
  • Chen KM, Sun YW, Cooper TK, Benitez G, Aliaga C, Zhu J, Gowda K, Amin S, El-Bayoumy K. 2018. Comparative tumorigenicity and DNA damage induced by dibenzo [def,p]chrysene and Its metabolites in the mouse ovary. Chem Res Toxicol. 31(11):1111–1118.
  • Chen Y, Ruan J, Sun F, Wang H, Yang S, Zhang Y, Yan J, Yu H, Guo Y, Zhang Y, et al. 2020. Anti-inflammatory limonoids from Cortex Dictamni. Front Chem. 8:73.
  • Chiang JY. 2013. Bile acid metabolism and signaling. Compr Physiol. 3(3):1191–1212.
  • Chien CC, Wu MS, Chou SW, Jargalsaikhan G, Chen YC. 2021. Roles of reactive oxygen species, mitochondrial membrane potential, and p53 in evodiamine-induced apoptosis and G2/M arrest of human anaplastic thyroid carcinoma cells. Chin Med. 16(1):134.
  • Czerska M, Mikołajewska K, Zieliński M, Gromadzińska J, Wąsowicz W. 2015. Today’s oxidative stress markers. Med Pr. 66(3):393–405.
  • Dadsena S, King LE, García-Sáez AJ. 2021. Apoptosis regulation at the mitochondria membrane level. Biochim Biophys Acta Biomembr. 1863(12):183716.
  • Diawara MM, Williams DE, Oganesian A, Spitsbergen J. 2000. Dietary psoralens induce hepatotoxicity in C57 mice. J Nat Toxins. 9(2):179–195.
  • Dickinson RG, King AR. 1991. Studies on the reactivity of acyl glucuronides–II. Interaction of diflunisal acyl glucuronide and its isomers with human serum albumin in vitro. Biochem Pharmacol. 42(12):2301–2306.
  • Fan Q, Zhao B, Wang C, Zhang J, Wu J, Wang T, Xu A. 2018. Subchronic toxicity studies of Cortex Dictamni extracts in mice and its potential hepatotoxicity mechanisms in vitro. Molecules. 23(10):2486.
  • Fan XR, Liu ZH, Feng WH, Liu XQ, Xiao CR, Yang LX, Wang ZM, Li C. 2017. Qualitative and quantitative analysis of Evodiae Fructus based on the UPLC technology. Chin J Chin Mater Med. 42(20):3945–3956.
  • Feng P, Hu X, Wu X, Dong J, Cai X. 2016. Characterization of an epoxide-derived metabolite of dictamnine using high-performance liquid chromatography with hybrid linear trap quadrupole orbitrap mass spectrometry. J Sep Sci. 39(24):4858–4865.
  • Fischer J, Zubel T, Jander K, Fix J, Trussina I, Gebhard D, Bergemann J, Bürkle A, Mangerich A. 2018. PARP1 protects from benzo[a]pyrene diol epoxide-induced replication stress and mutagenicity. Arch Toxicol. 92(3):1323–1340.
  • Galvan I, Wakamatsu K, Alonso-Alvarez C, Solano F. 2014. Buthionine sulfoximine diverts the melanogenesis pathway toward the production of more soluble and degradable pigments. Bioorg Med Chem Lett. 24(9):2150–2154.
  • Gao YD, Zhu A, Li LD, Zhang T, Wang S, Shan DP, Li YZ, Wang Q. 2021. Cytotoxicity and underlying mechanism of evodiamine in HepG2 cells. J Peking Univ Health Sci. 53(6):1107–1114.
  • Gavaraskar K, Dhulap S, Hirwani RR. 2015. Therapeutic and cosmetic applications of Evodiamine and its derivatives–a patent review. Fitoterapia. 106:22–35.
  • Gómez-Lechón MJ, Tolosa L, Donato MT. 2016. Metabolic activation and drug-induced liver injury: in vitro approaches for the safety risk assessment of new drugs. J Appl Toxicol. 36(6):752–768.
  • Gordon P, Khojasteh SC. 2015. A decades-long investigation of acute metabolism-based hepatotoxicity by herbal constituents: a case study of pennyroyal oil. Drug Metab Rev. 47(1):12–20.
  • Gould RL, Pazdro R. 2019. Impact of supplementary amino acids, micronutrients, and overall diet on glutathione homeostasis. Nutrients. 11(5):1056.
  • Guo W, Huang J, Wang N, Tan HY, Cheung F, Chen F, Feng Y. 2019. Integrating network pharmacology and pharmacological evaluation for deciphering the action mechanism of herbal formula Zuojin pill in suppressing hepatocellular carcinoma. Front Pharmacol. 10:1185.
  • Hai Y, Feng S, Wang L, Ma Y, Zhai Y, Wu Z, Zhang S, He X. 2017. Coordination mechanism and bio-evidence: reactive γ-ketoenal intermediated hepatotoxicity of psoralen and isopsoralen based on computer approach and bioassay. Molecules. 22(9):1451.
  • Hajnóczky G, Csordás G, Das S, Garcia-Perez C, Saotome M, Sinha Roy S, Yi M. 2006. Mitochondrial calcium signalling and cell death: approaches for assessing the role of mitochondrial Ca2+ uptake in apoptosis. Cell Calcium. 40(5-6):553–560.
  • Hamberger C, Kellert M, Schauer UM, Dekant W, Mally A. 2010. Hepatobiliary toxicity of furan: identification of furan metabolites in bile of male f344/n rats. Drug Metab Dispos. 38(10)::1698–1706.
  • Han EH, Kim HG, Im JH, Jeong TC, Jeong HG. 2009. Up-regulation of CYP1A1 by rutaecarpine is dependent on aryl hydrocarbon receptor and calcium. Toxicology. 266(1-3):38–47.
  • Hessel-Pras S, Braeuning A, Guenther G, Adawy A, Enge AM, Ebmeyer J, Henderson CJ, Hengstler JG, Lampen A, Reif R. 2020. The pyrrolizidine alkaloid senecionine induces CYP-dependent destruction of sinusoidal endothelial cells and cholestasis in mice. Arch Toxicol. 94(1):219–229.
  • Honkalammi J, Niemi M, Neuvonen PJ, Backman JT. 2012. Gemfibrozil is a strong inactivator of CYP2C8 in very small multiple doses. Clin Pharmacol Ther. 91(5):846–855.
  • Hosomi H, Fukami T, Iwamura A, Nakajima M, Yokoi T. 2011. Development of a highly sensitive cytotoxicity assay system for CYP3A4-mediated metabolic activation. Drug Metab Dispos. 39(8):1388–1395.
  • Hsia MT. 1982. Toxicological significance of dihydrodiol metabolites. J Toxicol Clin Toxicol. 19(6-7):737–758.
  • Huang W, Li X, Sun R. 2012. “Dose-time-toxicity” relationship study on hepatotoxicity caused by multiple dose water extraction components of Evodiae Fructus to mice. Chin J Chin Mater Med. 37(15):2223–2227.
  • Huang W, Zhao Y, Sun R. 2010. Experimental comparis on study on mice 's acute toxicity of different composition in Evodia Fructus. Chin J Pharmacov. 7(03):129–134.
  • Huang YX, Guo YM, Zhou YF, Zhang CE, Jing J, Liu SJ, Zhang NN, Song JY, Xiao XH, Wang JB. 2017. [Dictamni Cortex powder-induced liver injury based on integrated evidence chain]. Chin J Chin Mater Med. 42(3):600–606.
  • Hudson A, Lopez E, Almalki AJ, Roe AL, Calderón AI. 2018. A review of the toxicity of compounds found in herbal dietary supplements. Planta Med. 84(9-10):613–626.
  • Iwata H, Tezuka Y, Kadota S, Hiratsuka A, Watabe T. 2005. Mechanism-based inactivation of human liver microsomal CYP3A4 by rutaecarpine and limonin from Evodia fruit extract. Drug Metab Pharmacokinet. 20(1):34–45.
  • Jaeschke H, McGill MR, Ramachandran A. 2012. Oxidant stress, mitochondria, and cell death mechanisms in drug-induced liver injury: lessons learned from acetaminophen hepatotoxicity. Drug Metab Rev. 44(1):88–106.
  • Kalgutkar AS, Soglia JR. 2005. Minimising the potential for metabolic activation in drug discovery. Expert Opin Drug Metab Toxicol. 1(1):91–142.
  • Kapoor R, Kakkar P. 2012. Protective role of morin, a flavonoid, against high glucose induced oxidative stress mediated apoptosis in primary rat hepatocytes. PLoS One. 7(8):e41663.
  • Klier B, Schimmer O. 1999. Microsomal metabolism of dictamnine: identification of metabolites and evaluation of their mutagenicity in Salmonella typhimurium. Mutagenesis. 14(2):181–185.
  • Klomp F, Wenzel C, Drozdzik M, Oswald S. 2020. Drug-drug interactions involving intestinal and hepatic CYP1A enzymes. Pharmaceutics. 12(12):1201.
  • Klopčič I, Dolenc MS. 2019. Chemicals and drugs forming reactive quinone and quinone imine metabolites. Chem Res Toxicol. 32(1):1–34.
  • Koen YM, Hajovsky H, Liu K, Williams TD, Galeva NA, Staudinger JL, Hanzlik RP. 2012. Liver protein targets of hepatotoxic 4-bromophenol metabolites. Chem Res Toxicol. 25(8):1777–1786.
  • Koenigs LL, Trager WF. 1998. Mechanism-based inactivation of cytochrome P450 2B1 by 8-methoxypsoralen and several other furanocoumarins. Biochemistry. 37(38):13184–13193.
  • Korver S, Bowen J, Pearson K, Gonzalez RJ, French N, Park K, Jenkins R, Goldring C. 2021. The application of cytokeratin-18 as a biomarker for drug-induced liver injury. Arch Toxicol. 95(11):3435–3448.
  • Lai Y, Lu M, Gao X, Wu H, Cai Z. 2011. New evidence for toxicity of polybrominated diphenyl ethers: DNA adduct formation from quinone metabolites. Environ Sci Technol. 45(24):10720–10727.
  • Lang X, Zhang X, Wang D, Zhou W. 2020. In vitro and in vivo metabolic activation of obacunone, a bioactive and potentially hepatotoxic constituent of Dictamni Cortex. Planta Med. 86(10):686–695.
  • Langeswaran K, Gowthamkumar S, Vijayaprakash S, Revathy R, Balasubramanian MP. 2013. Influence of limonin on Wnt signalling molecule in HepG2 cell lines. J Nat Sci Biol Med. 4(1):126–133.
  • Lebeaupin C, Vallée D, Hazari Y, Hetz C, Chevet E, Bailly-Maitre B. 2018. Endoplasmic reticulum stress signalling and the pathogenesis of non-alcoholic fatty liver disease. J Hepatol. 69(4):927–947.
  • Lee SK, Lee DW, Jeon TW, Jin CH, Kim GH, Jun IH, Lee DJ, Kim SI, Kim DH, Jahng Y, et al. 2005. Characterization of the phase II metabolites of rutaecarpine in rat by liquid chromatography-electrospray ionization-tandem mass spectrometry. Xenobiotica. 35(12):1135–1145.
  • Lee SK, Lee JH, Yoo HH, Kim DH, Jahng Y, Jeong TC. 2006. Characterization of human liver cytochrome P450 enzymes involved in the metabolism of rutaecarpine. J Pharm Biomed Anal. 41(1):304–309.
  • Leung L, Kalgutkar AS, Obach RS. 2012. Metabolic activation in drug-induced liver injury. Drug Metab Rev. 44(1):18–33.
  • Li C, Lin D, Gao H, Hua H, Peng Y, Zheng J. 2015. N-acetyl lysine/glutathione-derived pyrroles as potential ex vivo biomarkers of bioactivated furan-containing compounds. Chem Res Toxicol. 28(3):384–393.
  • Li F, Dong YZ, Zhang D, Zhang XM, Lin ZJ, Zhang B. 2019. Molecular mechanisms involved in drug-induced liver injury caused by urate-lowering Chinese herbs: a network pharmacology study and biology experiments. PLoS One. 14(5):e0216948.
  • Li M, Wang C. 2020. Traditional uses, phytochemistry, pharmacology, pharmacokinetics and toxicology of the fruit of Tetradium ruticarpum: a review. J Ethnopharmacol. 263:113231.
  • Li W, Lin D, Gao H, Xu Y, Meng D, Smith CV, Peng Y, Zheng J. 2016. Metabolic activation of furan moiety makes Diosbulbin B hepatotoxic. Arch Toxicol. 90(4):863–872.
  • Li XY, Sun R. 2015. Study on efficacy and accompanying toxic and side effects of volatile oil of Evodia Fructus based on stomach cold syndrome model. Chin J Chin Mater Med. 40(19):3838–3844.
  • Li YY, Guo MQ, Li XM, Yang XW. 2020. Simultaneous qualitative and quantitative evaluation of the Coptidis Rhizoma and Euodiae Fructus Herbal Pair by using UHPLC-ESI-QTOF-MS and UHPLC-DAD. Molecules. 25(20):4782.
  • Li ZQ, Jiang LL, Zhao DS, Zhou J, Wang LL, Wu ZT, Zheng X, Shi ZQ, Li P, Li HJ. 2018. The modulatory role of CYP3A4 in dictamnine-induced hepatotoxicity. Front Pharmacol. 9:1033.
  • Li ZQ, Wang LL, Zhou J, Zheng X, Jiang Y, Li P, Li HJ. 2020. Integration of transcriptomics and metabolomics profiling reveals the metabolic pathways affected in dictamnine-induced hepatotoxicity in mice. J Proteomics. 213:103603.
  • Liang X, Li B, Wu F, Li T, Wang Y, Ma Q, Liang S. 2017. Bitterness and antibacterial activities of constituents from Evodia rutaecarpa. BMC Complement Altern Med. 17(1):180.
  • Liao WQ, Li B, Li L, Zhao JN. 2014. Study on molecular mechanism of Euodiae Fructus on liver toxicity in MICE. Chin. J Chin Mater Med. 39(24):4865–4868.
  • Lin D, Li C, Peng Y, Gao H, Zheng J. 2014. Cytochrome p450-mediated metabolic activation of diosbulbin B. Drug Metab Dispos. 42(10):1727–1736.
  • Lin D, Li W, Tian X, Peng Y, Zheng J. 2019. In vitro DNA adduction resulting from metabolic activation of diosbulbin B and 8-epidiosbulbin E acetate. Chem Res Toxicol. 32(1):38–48.
  • Liu L, Sun X, Guo Y, Ge K. 2022. Evodiamine induces ROS-dependent cytotoxicity in human gastric cancer cells via TRPV1/Ca2+ pathway. Chem Biol Interact. 351:109756.
  • Liu T, Sun L, Zhang Y, Wang Y, Zheng J. 2022. Imbalanced GSH/ROS and sequential cell death. J Biochem Mol Toxicol. 36(1):e22942.
  • Liu Y, Liu C, Liu Y, Ge Q, Sun C. 2020. Cytochrome P450 mediated bioactivation of rutaevin, a bioactive and potentially hepatotoxic component of Evodia rutaecarpa. Chem Res Toxicol. 33(12):3054–3064.
  • Liu Y, Zhou W, Mao Z, Chen Z. 2019. Analysis of Evodiae Fructus by capillary electrochromatography-mass spectrometry with methyl-vinylimidazole functionalized organic polymer monolilth as stationary phases. J Chromatogr A. 1602:474–480.
  • Lu D, Peterson LA. 2010. Identification of furan metabolites derived from cysteine-cis-2-butene-1,4-dial-lysine cross-links. Chem Res Toxicol. 23(1):142–151.
  • Lushchak VI. 2014. Free radicals, reactive oxygen species, oxidative stress and its classification. Chem Biol Interact. 224:164–175.
  • Ma R, Chen Y, Zhao YR, Tan XL, Zhou XD. 2018. Case report of liver damage by traditional Chinese medicine drug granules. Clin Misdiagn Misther. 31(06):84–86.
  • Man S, Qiu P, Li J, Zhang L, Gao W. 2017. Global metabolic profiling for the study of Rhizoma Paridis saponins-induced hepatotoxicity in rats. Environ Toxicol. 32(1):99–108.
  • McGill MR, Jaeschke H. 2013. Metabolism and disposition of acetaminophen: recent advances in relation to hepatotoxicity and diagnosis. Pharm Res. 30(9):2174–2187.
  • Naisbitt DJ, Sanderson LS, Meng X, Stachulski AV, Clarke SE, Park BK. 2007. Investigation of the immunogenicity of diclofenac and diclofenac metabolites. Toxicol Lett. 168(1)::45–50.
  • Nan N, Gong MX, Wang Q, Li MJ, Xu R, Ma Z, Wang SH, Zhao H, Xu YS. 2022. Wuzhuyu Decoction relieves hyperalgesia by regulating central and peripheral 5-HT in chronic migraine model rats. Phytomedicine. 96:153905.
  • Navarro VJ, Khan I, Björnsson E, Seeff LB, Serrano J, Hoofnagle JH. 2017. Liver injury from herbal and dietary supplements. Hepatology. 65(1):363–373.
  • Pariser D, Wyles R. 1980. Toxic hepatitis from oral methoxsalen photochemotherapy (PUVA). J Am Acad Dermatol. 3(3):248–250.
  • Peterson LA. 2013. Reactive metabolites in the biotransformation of molecules containing a furan ring. Chem Res Toxicol. 26(1):6–25.
  • Peterson LA, Naruko KC, Predecki DP. 2000. A reactive metabolite of furan, cis-2-butene-1,4-dial, is mutagenic in the Ames assay. Chem Res Toxicol. 13(7):531–534.
  • Regan SL, Maggs JL, Hammond TG, Lambert C, Williams DP, Park BK. 2010. Acyl glucuronides: the good, the bad and the ugly. Biopharm Drug Dispos. 31(7):367–395.
  • Ren W, Xin SK, Han LY, Zuo R, Li Y, Gong MX, Wei XL, Zhou YY, He J, Wang HJ, et al. 2015. Comparative metabolism of four limonoids in human liver microsomes using ultra-high-performance liquid chromatography coupled with high-resolution LTQ-Orbitrap mass spectrometry. Rapid Commun Mass Spectrom. 29(21):2045–2056.
  • Rezatabar S, Karimian A, Rameshknia V, Parsian H, Majidinia M, Kopi TA, Bishayee A, Sadeghinia A, Yousefi M, Monirialamdari M, et al. 2019. RAS/MAPK signaling functions in oxidative stress, DNA damage response and cancer progression. J Cell Physiol. 234(9):14951–14965.
  • Rivero Osimani VL, Valdez SR, Guiñazú N, Magnarelli G. 2016. Alteration of syncytiotrophoblast mitochondria function and endothelial nitric oxide synthase expression in the placenta of rural residents. Reprod Toxicol. 61:47–57.
  • Rowland A, Miners JO, Mackenzie PI. 2013. The UDP-glucuronosyltransferases: their role in drug metabolism and detoxification. Int J Biochem Cell Biol. 45(6):1121–1132.
  • Schempp CM, Simon-Haarhaus B, Krieger R, Simon JC. 2006. Solar simulator-induced phototoxicity of the furoquinoline alkaloid dictamnine compared to 8-methoxypsoralen and 5-methoxypsoralen. Planta Med. 72(10):941–943.
  • Shi F, Pan H, Cui B, Li Y, Huang L, Lu Y. 2019. Dictamnine-induced hepatotoxicity in mice: the role of metabolic activation of furan. Toxicol Appl Pharmacol. 364:68–76.
  • Shi YS, Xia HM, Wu CH, Li CB, Duan CC, Che C, Zhang XJ, Li HT, Zhang Y, Zhang XF. 2020. Novel nortriterpenoids with new skeletons and limonoids from the fruits of Evodia rutaecarpa and their bioactivities. Fitoterapia. 142:104503.
  • Stephens RB, Cooper A. 1999. Hepatitis from 5-methoxypsoralen occurring in a patient with previous flucloxacillin hepatitis. Australas J Dermatol. 40(4):217–219.
  • Sun Q, Xie L, Song J, Li X. 2020. Evodiamine: a review of its pharmacology, toxicity, pharmacokinetics and preparation researches. J Ethnopharmacol. 262:113164.
  • Tan Q, Zhang J. 2016. Evodiamine and Its role in chronic diseases. Adv Exp Med Biol. 929:315–328.
  • Tan R, Hu Z, Zhou M, Liu Y, Wang Y, Zou Y, Li K, Zhang S, Pan J, Peng Y, et al. 2022. Diosbulbin B: an important component responsible for hepatotoxicity and protein covalent binding induced by Dioscorea bulbifera L. Phytomedicine. 102:154174.
  • Tang W. 2003. The metabolism of diclofenac–enzymology and toxicology perspectives. Curr Drug Metab. 4(4):319–329.
  • Tian KM, Li JJ, Xu SW. 2019. Rutaecarpine: a promising cardiovascular protective alkaloid from Evodia rutaecarpa (Wu Zhu Yu). Pharmacol Res. 141:541–550.
  • Tozlovanu M, Faucet-Marquis V, Pfohl-Leszkowicz A, Manderville RA. 2006. Genotoxicity of the hydroquinone metabolite of ochratoxin A: structure-activity relationships for covalent DNA adduction. Chem Res Toxicol. 19(9):1241–1247.
  • Ueng YF, Ko HC, Chen CF, Wang JJ, Chen KT. 2002. Modulation of drug-metabolizing enzymes by extracts of a herbal medicine Evodia rutaecarpa in C57BL/6J mice. Life Sci. 71(11):1267–1277.
  • Vikram A, Jayaprakasha GK, Jesudhasan PR, Pillai SD, Patil BS. 2012. Obacunone represses Salmonella pathogenicity islands 1 and 2 in an envZ-dependent fashion. Appl Environ Microbiol. 78(19):7012–7022.
  • Wang C, Hao Z, Zhou J, Zhang L, Sun Y, Liang C. 2017. Rutaecarpine alleviates renal ischemia reperfusion injury in rats by suppressing the JNK/p38 MAPK signaling pathway and interfering with the oxidative stress response. Mol Med Rep. 16(1):922–928.
  • Wang K, Li W, Chen J, Peng Y, Zheng J. 2015. Detection of cysteine- and lysine-based protein adductions by reactive metabolites of 2,5-dimethylfuran. Anal Chim Acta. 896:93–101.
  • Wang K, Rao J, Zhang T, Gao Q, Zhang J, Guang C, Ding L, Qiu F. 2020. Metabolic activation and covalent protein binding of berberrubine: insight into the underlying mechanism related to its hepatotoxicity. Drug Des Devel Ther. 14:4423–4438.
  • Wang M, Tan J, Miao Y, Li M, Zhang Q. 2018. Role of Ca2+ and ion channels in the regulation of apoptosis under hypoxia. Histol Histopathol. 33(3):237–246.
  • Wen B, Gorycki P. 2019. Bioactivation of herbal constituents: mechanisms and toxicological relevance. Drug Metab Rev. 51(4):453–497.
  • Wen B, Roongta V, Liu L, Moore DJ. 2014. Metabolic activation of the indoloquinazoline alkaloids evodiamine and rutaecarpine by human liver microsomes: dehydrogenation and inactivation of cytochrome P450 3A4. Drug Metab Dispos. 42(6):1044–1054.
  • Wu L, Chen Y, Liu H, Zhan Z, Liang Z, Zhang T, Cai Z, Ye L, Liu M, Zhao J, et al. 2018. Emodin-induced hepatotoxicity was exacerbated by probenecid through inhibiting UGTs and MRP2. Toxicol Appl Pharmacol. 359:91–101.
  • Wu WS, Chien CC, Chen YC, Chiu WT. 2016. Protein kinase RNA-like endoplasmic reticulum kinase-mediated Bcl-2 protein phosphorylation contributes to evodiamine-induced apoptosis of human renal cell carcinoma cells. PLoS One. 11(8):e0160484.
  • Yang X, Liu Y, Bao Z, Jiang Y, Tu P. 2010. [Simultaneous determination of three active compounds in root barks of Dictamnus dasycarpus by RP-HPLC]. Zhongguo Zhong Yao Za Zhi. 35(2):187–190.
  • Xiang P, Cao QH, Dong QM, Yang XJ, Tang JJ, Bai H. 2018. Furan-site transformations of obacunone as potent insecticidal agents. Heliyon. 4(12):e01064.
  • Yang XB, Qian P, Yang XW, Liu JX, Gong NB, Lv Y. 2013. Limonoid constituents of Euodia rutaecarpa var. bodinieri and their inhibition on NO production in lipopolysaccharide-activated RAW264.7 macrophages. J Asian Nat Prod Res. 15(10):1130–1138.
  • Ye X, Li W, Yan Y, Mao C, Cai R, Xu H, Yang X. 2010. Effects of cytochrome P4503A inducer dexamethasone on the metabolism and toxicity of triptolide in rat. Toxicol Lett. 192(2):212–220.
  • You G, Yang R, Wei Y, Hu W, Gan L, Xie C, Zheng Z, Liu Z, Liao R, Ye L. 2021. The detoxification effect of cytochrome P450 3A4 on gelsemine-induced toxicity. Toxicol Lett. 353:34–42.
  • You Y, Wang X, Ma K, Li J, Peng Y, Zheng J. 2021. Metabolic activation of atomoxetine mediated by cytochrome P450 2D6. Chem Res Toxicol. 34(9):2135–2144.
  • Yu J, Deng P, Zhong D, Chen X. 2014. Identification of amino acid and glutathione N-conjugates of toosendanin: bioactivation of the furan ring mediated by CYP3A4. Chem Res Toxicol. 27(9):1598–1609.
  • Yu Q, Jiang LL, Luo N, Fan YX, Ma J, Li P, Li HJ. 2017. Enhanced absorption and inhibited metabolism of emodin by 2, 3, 5, 4'-tetrahydroxystilbene-2-O-β-D-glucopyranoside: possible mechanisms for Polygoni Multiflori Radix-induced liver injury. Chin J Nat Med. 15(6):451–457.
  • Yue J, López JM. 2020. Understanding MAPK signaling pathways in apoptosis. Int J Mol Sci. 21(7):2346.
  • Zhang C, Wang N, Xu Y, Tan HY, Li S, Feng Y. 2018. Molecular mechanisms involved in oxidative stress-associated liver injury induced by Chinese herbal medicine: an experimental evidence-based literature review and network pharmacology study. Int J Mol Sci. 19(9):2745.
  • Zhang FL, He X, Zhai YR, He LN, Zhang SC, Wang LL, Yang AH, An LJ. 2015. Mechanism-based inhibition of CYPs and RMs-induced hepatoxicity by rutaecarpine. Xenobiotica. 45(11):978–989.
  • Zhang IX, Raghavan M, Satin LS. 2020. The endoplasmic reticulum and calcium homeostasis in pancreatic beta cells. Endocrinology. 161(2):bqz028.
  • Zhang W, Wang M, Song H, Gao C, Wang D, Hua H, Pan Y, Liu X. 2021. CYP3A4 inducer aggravates big flower Evodiae Fructus-induced hepatotoxicity whereas limonin attenuates its hepatotoxicity. J Ethnopharmacol. 264:113277.
  • Zhang YT, Zhang DF, Ge NY, Zhu GH, Hao C, Zhang Y, Chen RJ. 2016. Effect of evodiamine on CYP enzymes in rats by a cocktail method. Pharmacology. 97(5-6):218–223.
  • Zhao HM, Liu Y, Huang XY, Liu XK, Chen F, Zhang XY, Liu FC, Lu XY, Wang Y, Liu DY. 2019. Pharmacological mechanism of Sishen Wan attenuated experimental chronic colitis by inhibiting wnt/β-catenin pathway. J Ethnopharmacol. 240:111936.
  • Zhao Y, Zhao Y, Zhou X, Gong X. 2014. Development and validation of an UPLC-ESI-MS/MS method for determination of dehydroevodiamine, limonin, evodiamine, and rutaecarpine in Evodiae Fructus. Pharmacogn Mag. 10(39):374–383.
  • Zhao Z, He X, Han W, Chen X, Liu P, Zhao X, Wang X, Zhang L, Wu S, Zheng X. 2019. Genus Tetradium L.: a comprehensive review on traditional uses, phytochemistry, and pharmacological activities. J Ethnopharmacol. 231:337–354.
  • Zheng L, Cao J, Lu D, Ji L, Peng Y, Zheng J. 2015. Imperatorin is a mechanism-based inactivator of CYP2B6. Drug Metab Dispos. 43(1):82–88.
  • Zheng X, Wang X, Ding Z, Li W, Peng Y, Zheng J. 2021. Metabolic activation of deferiprone mediated by CYP2A6. Xenobiotica. 51(11):1282–1291.
  • Zhou SF, Xue CC, Yu XQ, Wang G. 2007. Metabolic activation of herbal and dietary constituents and its clinical and toxicological implications: an update. Curr Drug Metab. 8(6):526–553.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.